Clinical Trials

NCT05172245 | RECRUITING | PHASE1
46 participants

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-18
Start Date:
2022-09-19
Completion:
2027-07-01
Conditions
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Head and Neck Carcinoma of Unknown Primary
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Locally Advanced Hypopharyngeal Squamous Cell Carcinoma
  • Locally Advanced Laryngeal Squamous Cell Carcinoma
  • Locally Advanced Nasal Cavity Squamous Cell Carcinoma
  • Locally Advanced Oral Cavity Squamous Cell Carcinoma
  • Locally Advanced Oropharyngeal Squamous Cell Carcinoma
  • Locally Advanced Paranasal Sinus Squamous Cell Carcinoma
  • Locally Advanced Sinonasal Squamous Cell Carcinoma
  • Maxillary Sinus Squamous Cell Carcinoma
  • Stage III Hypopharyngeal Carcinoma AJCC v8
  • Stage III Laryngeal Cancer AJCC v8
  • Stage III Lip and Oral Cavity Cancer AJCC v8
  • Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage III Sinonasal Cancer AJCC v8
  • Stage IVA Hypopharyngeal Carcinoma AJCC v8
  • Stage IVA Laryngeal Cancer AJCC v8
  • Stage IVA Lip and Oral Cavity Cancer AJCC v8
  • Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage IVA Sinonasal Cancer AJCC v8
  • Stage IVB Hypopharyngeal Carcinoma AJCC v8
  • Stage IVB Laryngeal Cancer AJCC v8
  • Stage IVB Lip and Oral Cavity Cancer AJCC v8
  • Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage IVB Sinonasal Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
  • RADIATION
No Results Yet
NCT05144191 | ACTIVE_NOT_RECRUITING | NA
313 participants

Insignia™ Hip Stem Outcomes Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-18
Start Date:
2022-02-07
Completion:
2034-04-02
Conditions
  • Hip Osteoarthritis
  • Avascular Necrosis
  • Rheumatoid Arthritis
  • Post-traumatic Osteoarthritis
  • Femoral Neck Fractures
  • Trochanteric Fractures
  • Surgery
Interventions
  • DEVICE
No Results Yet
NCT05115474 | RECRUITING | PHASE2
170 participants

Study of Screening Brain MRIs in Stage IV Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-18
Start Date:
2021-12-21
Completion:
2026-06-16
Conditions
  • Triple Negative Breast Cancer
  • HER2-positive Breast Cancer
  • Hormone Receptor-positive Breast Cancer
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT05096663 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
82 participants

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-18
Start Date:
2022-03-15
Completion:
2027-06-30
Conditions
  • Advanced Lung Non-Small Cell Carcinoma
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
  • Stage IIIA Lung Cancer AJCC v8
  • Stage IIIB Lung Cancer AJCC v8
  • Stage IIIC Lung Cancer AJCC v8
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • DIETARY_SUPPLEMENT
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT05051657 | COMPLETED | NA
28 participants

Evaluation of the Express Plus Range

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-18
Start Date:
2021-06-14
Completion:
2025-09-30
Conditions
  • Phenylketonurias
  • PKU
  • Homocystinuria
  • Maple Syrup Urine Disease
  • Hereditary Tyrosinemia
  • Glutaric Acidemia I
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT05010603 | RECRUITING
10000 participants

Late Onset Alzheimer's Disease

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-18
Start Date:
2016-11-15
Completion:
2027-04-30
Conditions
  • Alzheimer Disease
Interventions
  • GENETIC
  • OTHER
No Results Yet
NCT04941716 | RECRUITING | PHASE2
20 participants

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-18
Start Date:
2023-05-31
Completion:
2027-08-10
Conditions
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Small Lymphocytic Lymphoma
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page